PTSD-like phenotype of mice lacking GIT2
PTSD-like phenotype of mice lacking GIT2
批准号:
8149966
负责人:
Richard T Premont
金额:
$19.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-28 至 2012-06-30
关键词:
ADP-Ribosylation FactorsAblationAddressAffectAnimal ModelAnxietyAnxiety DisordersAppearanceBehaviorBehavioralBindingBiologicalBiological ModelsBrainBrain regionCell Surface ReceptorsCell physiologyCellsCentrosomeCharacteristicsComplexDataDiagnosisDiseaseEmotionalEmployee StrikesEndocrineEndocytosisEventExhibitsExposure toExtinction (Psychology)FamilyFeedbackFocal AdhesionsFrightFundingFutureG protein coupled receptor kinaseGIT1 geneGIT2 geneGRKGTP-Binding ProteinsGTPase-Activating ProteinsGeneticGoalsGuanine Nucleotide Exchange FactorsHormonalHumanHuntington DiseaseHydrocortisoneImageInvestigationKnock-outKnockout MiceLearningLifeLocationMaintenanceMajor Depressive DisorderMemoryMusNeuronsNumbnessOrganismPIX proteinPatientsPatternPharmacotherapyPhenocopyPhenotypePhosphotransferasesPhysiologicalPlayPost-Traumatic Stress DisordersPrevalenceProtein KinaseProteinsPsychotherapyRecoveryRegulationResearchRestRoleSelective Serotonin Reuptake InhibitorSerumSeveritiesSeverity of illnessSignal PathwaySignal TransductionSignal Transduction PathwaySignaling ProteinSourceStimulusStressSubstance abuse problemSymptomsSyndromeTrainingTraumaValidationVesiclebasebetaPIX proteinbiobehaviorconditioned fearexperiencehuman Huntingtin proteinhypothalamic-pituitary-adrenal axisinsightmigrationneurochemistryprotein functionpublic health relevanceresearch studyresponserhoscaffoldsynaptogenesistrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The GIT1 and GIT2 proteins are GTPase-activating proteins for the Arf small GTP-binding proteins. Together with the alpha-PIX and beta-PIX proteins (themselves guanine nucleotide exchange factors for Rho family small GTP-binding proteins), GIT proteins form an oligomeric signaling scaffolding complex. GIT/PIX complexes have been shown to bind to a variety of protein kinases as well as other signaling proteins, and to localize to several distinct cellular locations through interaction with specific partners. Although GIT and PIX proteins have been implicated in a wide variety of cellular processes, including vesicle trafficking, focal adhesion dynamics and synapse formation, little is known of the physiological functions of these proteins. To address this, we created GIT1-KO and GIT2-KO knockout mouse lines, with inactivated GIT1 or GIT2 genes, and subjected them to unbiased behavioral screens. One striking difference we noted between GIT1-KO and GIT2-KO mice is that GIT1-KO mice are scarcely affected by fearful stimuli, while GIT2-KO mice greatly over- respond to invoked fear. Since we have previously shown that both GIT1 and GIT2 function as Arf GAPs, form similar GIT/PIX complexes, and are widely expressed throughout the brain, the mechanistic reasons for such dissimilar behavioral effects remain unknown. The main hypothesis underlying this study is that GIT2 is an important regulator of learned fear behavior, and lack of GIT2 predisposes mice to a syndrome with high similarity to post-traumatic stress disorder (PTSD). The major aims of this project are to define the effect of SSRI treatment on fear behavior in GIT2-KO mice, to define the hormonal/neurochemical responses to stress in GIT2-KO mice, and to identify cellular signaling mechanisms through which GIT2 affects fear responses in mice. A more complete understanding of altered fear responses in GIT2-KO mice will allow validation of GIT2- KO mice as an animal model for human PTSD.
PUBLIC HEALTH RELEVANCE: The genetic and/or neurochemical bases for the inability to overcome trauma-induced fear in PTSD remains mostly unknown, and treatment options are limited. Mice deficient in the GIT2 protein overrespond to conditioned fear in a manner reminiscent of human PTSD. A deeper understanding of how GIT2 functions to regulate anxiety and the extinction of fear may provide insights into human fear and anxiety disorders such as PTSD.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0194350
发表时间:
2018
期刊:
PloS one
影响因子:
3.7
作者:
[Martyn AC, Toth K, Schmalzigaug R, Hedrick NG, Rodriguiz RM, Yasuda R, Wetsel WC, Premont RT]
通讯作者:
Premont RT
DOI:
10.1016/j.mri.2020.09.023
发表时间:
2021-03
期刊:
Magnetic resonance imaging
影响因子:
2.5
作者:
[Badea A, Schmalzigaug R, Kim W, Bonner P, Ahmed U, Johnson GA, Cofer G, Foster M, Anderson RJ, Badea C, Premont RT]
通讯作者:
Premont RT
PTSD-like phenotype of mice lacking GIT2
-
批准号:8055248
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2010
-
负责人:Richard T Premont
-
依托单位:
Dopamine Receptor Regulation by GRKs in Drug Abuse
-
批准号:6933207
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2004
-
负责人:Richard T Premont
-
依托单位:
Dopamine Receptor Regulation by GRKs in Drug Abuse
-
批准号:7049416
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2004
-
负责人:Richard T Premont
-
依托单位:
Dopamine Receptor Regulation by GRKs in Drug Abuse
-
批准号:7217257
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2004
-
负责人:Richard T Premont
-
依托单位:
Dopamine Receptor Regulation by GRKs in Drug Abuse
-
批准号:7388826
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2004
-
负责人:Richard T Premont
-
依托单位:
Dopamine Receptor Regulation by GRKs in Drug Abuse
-
批准号:6780153
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2004
-
负责人:Richard T Premont
-
依托单位:
SIGNALING PATHWAYS OF ARF GTPASES AND ARF GAPS
-
批准号:6261289
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2001
-
负责人:Richard T Premont
-
依托单位:
SIGNALING PATHWAYS OF ARF GTPASES AND ARF GAPS
-
批准号:6520095
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2001
-
负责人:Richard T Premont
-
依托单位:
SIGNALING PATHWAYS OF ARF GTPASES AND ARF GAPS
-
批准号:6889513
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2001
-
负责人:Richard T Premont
-
依托单位:
SIGNALING PATHWAYS OF ARF GTPASES AND ARF GAPS
-
批准号:6636350
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2001
-
负责人:Richard T Premont
-
依托单位:
SIGNALING PATHWAYS OF ARF GTPASES AND ARF GAPS
-
批准号:6742455
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2001
-
负责人:Richard T Premont
-
依托单位:
海外基金